We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
How to use an interrupted time series to evaluate your digital health product.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Apply for an authorisation to manufacture extemporaneous preparations, autogenous vaccines, stem cell products or blood products for non-food animals.
The Intellectual Property Office offers different methods of accelerating the processing of your patent application.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
Guidance to help UK administered aeroplane operators comply with the Carbon Offsetting and Reduction Scheme for International Aviation (CORSIA).
Pharmacovigilance system requirements
Evaluation of the Reducing Parental Conflict programme (RPC) from phase one, 2018 to 2022.
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
How to use a before-and-after study to evaluate your digital health product.
Information for pregnant women with singleton (having only one baby) and twin pregnancies who have received a higher-chance result from the combined or quadruple screening test
How you import from and export to Côte d’Ivoire (Ivory Coast).
How GBN’s technology selection process for Small Modular Reactors (SMRs) will work.
How to apply for marketing authorisation via this new procedure.
How investigators and sponsors should manage clinical trials during COVID-19
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).